Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0266 Transporter Info | ||||
Gene Name | SLC2A8 | ||||
Transporter Name | Glucose transporter type 8 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Hepatocellular carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in hepatocellular carcinoma | [ 1 ] | |||
Location |
5'UTR (cg00797102) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.84E+00 | Statistic Test | p-value:4.74E-17; Z-score:-2.99E+00 | ||
Methylation in Case |
3.02E-01 (Median) | Methylation in Control | 5.56E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in hepatocellular carcinoma | [ 1 ] | |||
Location |
TSS1500 (cg00114012) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:2.03E-09; Z-score:-1.84E+00 | ||
Methylation in Case |
6.28E-01 (Median) | Methylation in Control | 7.70E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC2A8 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg06178383) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.52E+00 | Statistic Test | p-value:1.98E-17; Z-score:-2.38E+00 | ||
Methylation in Case |
2.50E-01 (Median) | Methylation in Control | 3.81E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC2A8 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg14250560) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:6.55E-06; Z-score:1.13E+00 | ||
Methylation in Case |
7.93E-01 (Median) | Methylation in Control | 7.40E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC2A8 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg14479094) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.69E-04; Z-score:8.23E-01 | ||
Methylation in Case |
8.00E-01 (Median) | Methylation in Control | 7.71E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC2A8 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg14018434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:1.44E-03; Z-score:4.52E-01 | ||
Methylation in Case |
8.99E-01 (Median) | Methylation in Control | 8.93E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
5'UTR (cg21202529) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:7.74E-07; Z-score:1.38E+00 | ||
Methylation in Case |
8.64E-01 (Median) | Methylation in Control | 7.29E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
TSS200 (cg18588052) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:8.38E-04; Z-score:-6.24E-01 | ||
Methylation in Case |
6.55E-02 (Median) | Methylation in Control | 7.16E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC2A8 in pancretic ductal adenocarcinoma | [ 2 ] | |||
Location |
Body (cg19235418) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:1.42E-03; Z-score:-1.99E-01 | ||
Methylation in Case |
8.65E-01 (Median) | Methylation in Control | 8.70E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg00114012) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.91E+00 | Statistic Test | p-value:2.73E-10; Z-score:-1.12E+01 | ||
Methylation in Case |
3.34E-01 (Median) | Methylation in Control | 6.37E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in bladder cancer | [ 3 ] | |||
Location |
Body (cg00577364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.09E-02; Z-score:-1.45E+00 | ||
Methylation in Case |
8.65E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg00114012) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:9.92E-05; Z-score:-8.87E-01 | ||
Methylation in Case |
7.25E-01 (Median) | Methylation in Control | 7.58E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in breast cancer | [ 4 ] | |||
Location |
Body (cg14250560) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:4.70E-03; Z-score:-8.05E-01 | ||
Methylation in Case |
6.90E-01 (Median) | Methylation in Control | 7.88E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC2A8 in breast cancer | [ 4 ] | |||
Location |
Body (cg14479094) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:7.52E-03; Z-score:1.03E+00 | ||
Methylation in Case |
8.45E-01 (Median) | Methylation in Control | 8.10E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg00114012) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:1.43E-07; Z-score:2.60E+00 | ||
Methylation in Case |
8.82E-01 (Median) | Methylation in Control | 8.16E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg14250560) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:2.13E-04; Z-score:-1.28E+00 | ||
Methylation in Case |
7.92E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC2A8 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg03804985) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:3.06E-02; Z-score:4.92E-02 | ||
Methylation in Case |
2.51E-02 (Median) | Methylation in Control | 2.49E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg11346522) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.21E+00 | Statistic Test | p-value:5.90E-05; Z-score:-1.68E+00 | ||
Methylation in Case |
4.93E-01 (Median) | Methylation in Control | 5.98E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg18313899) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.52E+00 | Statistic Test | p-value:5.32E-07; Z-score:7.09E+00 | ||
Methylation in Case |
3.20E-01 (Median) | Methylation in Control | 1.27E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC2A8 in colon adenocarcinoma | [ 6 ] | |||
Location |
Body (cg26607031) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:4.46E-03; Z-score:7.21E-01 | ||
Methylation in Case |
3.98E-01 (Median) | Methylation in Control | 3.51E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg00114012) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.28E+00 | Statistic Test | p-value:8.38E-09; Z-score:-2.28E+00 | ||
Methylation in Case |
6.26E-01 (Median) | Methylation in Control | 7.98E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg14250560) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:4.76E-03; Z-score:-1.01E+00 | ||
Methylation in Case |
7.75E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC2A8 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg00757413) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:3.35E-02; Z-score:6.00E-01 | ||
Methylation in Case |
1.13E-01 (Median) | Methylation in Control | 1.02E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg00114012) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:1.33E-10; Z-score:1.30E+00 | ||
Methylation in Case |
8.73E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in HIV infection | [ 8 ] | |||
Location |
Body (cg14250560) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:6.10E-07; Z-score:2.19E+00 | ||
Methylation in Case |
6.27E-01 (Median) | Methylation in Control | 5.45E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg00114012) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:5.33E-03; Z-score:1.39E+00 | ||
Methylation in Case |
7.61E-01 (Median) | Methylation in Control | 6.90E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in lung adenocarcinoma | [ 9 ] | |||
Location |
Body (cg14479094) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:6.19E-03; Z-score:1.45E+00 | ||
Methylation in Case |
8.79E-01 (Median) | Methylation in Control | 8.51E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
Body (cg00577364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.54E+00 | Statistic Test | p-value:2.98E-05; Z-score:1.33E+00 | ||
Methylation in Case |
6.02E-01 (Median) | Methylation in Control | 3.91E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
Body (cg00757413) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:3.89E-05; Z-score:9.20E-01 | ||
Methylation in Case |
8.99E-01 (Median) | Methylation in Control | 8.25E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC2A8 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
Body (cg03804985) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.23E+00 | Statistic Test | p-value:4.37E-04; Z-score:1.21E+00 | ||
Methylation in Case |
7.81E-01 (Median) | Methylation in Control | 6.35E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC2A8 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
Body (cg13692482) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.29E+00 | Statistic Test | p-value:3.83E-02; Z-score:-8.34E-01 | ||
Methylation in Case |
1.56E-01 (Median) | Methylation in Control | 2.01E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC2A8 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
Body (cg14018434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:4.22E-02; Z-score:4.01E-01 | ||
Methylation in Case |
2.00E-01 (Median) | Methylation in Control | 1.75E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC2A8 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
Body (cg14250560) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.24E+00 | Statistic Test | p-value:4.37E-02; Z-score:5.64E-01 | ||
Methylation in Case |
1.65E-02 (Median) | Methylation in Control | 1.34E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC2A8 in atypical teratoid rhabdoid tumor | [ 10 ] | |||
Location |
Body (cg14479094) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:4.65E-02; Z-score:2.42E-01 | ||
Methylation in Case |
8.11E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in panic disorder | [ 11 ] | |||
Location |
Body (cg14250560) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.20E+00 | Statistic Test | p-value:2.92E-02; Z-score:-3.93E-01 | ||
Methylation in Case |
8.25E-02 (Median) | Methylation in Control | 1.82E-01 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in papillary thyroid cancer | [ 12 ] | |||
Location |
Body (cg14479094) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:1.04E-08; Z-score:1.40E+00 | ||
Methylation in Case |
9.09E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC2A8 in systemic lupus erythematosus | [ 13 ] | |||
Location |
Body (cg00577364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:3.17E-02; Z-score:-3.21E-01 | ||
Methylation in Case |
9.09E-01 (Median) | Methylation in Control | 9.15E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC2A8 in systemic lupus erythematosus | [ 13 ] | |||
Location |
Body (cg03804985) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:4.74E-02; Z-score:1.88E-01 | ||
Methylation in Case |
3.12E-02 (Median) | Methylation in Control | 2.96E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
30 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-1249 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1249 | miRNA Mature ID | miR-1249-5p | ||
miRNA Sequence |
AGGAGGGAGGAGAUGGGCCAAGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon2 |
miR-1587 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1587 | miRNA Mature ID | miR-1587 | ||
miRNA Sequence |
UUGGGCUGGGCUGGGUUGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon3 |
miR-3135b directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3135b | miRNA Mature ID | miR-3135b | ||
miRNA Sequence |
GGCUGGAGCGAGUGCAGUGGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon4 |
miR-3620 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3620 | miRNA Mature ID | miR-3620-5p | ||
miRNA Sequence |
GUGGGCUGGGCUGGGCUGGGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon5 |
miR-3652 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3652 | miRNA Mature ID | miR-3652 | ||
miRNA Sequence |
CGGCUGGAGGUGUGAGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon6 |
miR-3943 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3943 | miRNA Mature ID | miR-3943 | ||
miRNA Sequence |
UAGCCCCCAGGCUUCACUUGGCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon7 |
miR-4323 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4323 | miRNA Mature ID | miR-4323 | ||
miRNA Sequence |
CAGCCCCACAGCCUCAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon8 |
miR-4430 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4430 | miRNA Mature ID | miR-4430 | ||
miRNA Sequence |
AGGCUGGAGUGAGCGGAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon9 |
miR-4492 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4492 | miRNA Mature ID | miR-4492 | ||
miRNA Sequence |
GGGGCUGGGCGCGCGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon10 |
miR-4498 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4498 | miRNA Mature ID | miR-4498 | ||
miRNA Sequence |
UGGGCUGGCAGGGCAAGUGCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon11 |
miR-4510 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4510 | miRNA Mature ID | miR-4510 | ||
miRNA Sequence |
UGAGGGAGUAGGAUGUAUGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon12 |
miR-4656 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4656 | miRNA Mature ID | miR-4656 | ||
miRNA Sequence |
UGGGCUGAGGGCAGGAGGCCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon13 |
miR-4675 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4675 | miRNA Mature ID | miR-4675 | ||
miRNA Sequence |
GGGGCUGUGAUUGACCAGCAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon14 |
miR-4741 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4741 | miRNA Mature ID | miR-4741 | ||
miRNA Sequence |
CGGGCUGUCCGGAGGGGUCGGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon15 |
miR-5001 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5001 | miRNA Mature ID | miR-5001-5p | ||
miRNA Sequence |
AGGGCUGGACUCAGCGGCGGAGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon16 |
miR-5089 directly targets SLC2A8 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5089 | miRNA Mature ID | miR-5089-5p | ||
miRNA Sequence |
GUGGGAUUUCUGAGUAGCAUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon17 |
miR-548m directly targets SLC2A8 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-548m | miRNA Mature ID | miR-548m | ||
miRNA Sequence |
CAAAGGUAUUUGUGGUUUUUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon18 |
miR-5587 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5587 | miRNA Mature ID | miR-5587-3p | ||
miRNA Sequence |
GCCCCGGGCAGUGUGAUCAUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon19 |
miR-6127 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6127 | miRNA Mature ID | miR-6127 | ||
miRNA Sequence |
UGAGGGAGUGGGUGGGAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon20 |
miR-6129 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6129 | miRNA Mature ID | miR-6129 | ||
miRNA Sequence |
UGAGGGAGUUGGGUGUAUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon21 |
miR-6130 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6130 | miRNA Mature ID | miR-6130 | ||
miRNA Sequence |
UGAGGGAGUGGAUUGUAUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon22 |
miR-6133 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6133 | miRNA Mature ID | miR-6133 | ||
miRNA Sequence |
UGAGGGAGGAGGUUGGGUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon23 |
miR-619 directly targets SLC2A8 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-619 | miRNA Mature ID | miR-619-5p | ||
miRNA Sequence |
GCUGGGAUUACAGGCAUGAGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon24 |
miR-6506 directly targets SLC2A8 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6506 | miRNA Mature ID | miR-6506-5p | ||
miRNA Sequence |
ACUGGGAUGUCACUGAAUAUGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon25 |
miR-6515 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6515 | miRNA Mature ID | miR-6515-5p | ||
miRNA Sequence |
UUGGAGGGUGUGGAAGACAUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon26 |
miR-6797 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6797 | miRNA Mature ID | miR-6797-5p | ||
miRNA Sequence |
AGGAGGGAAGGGGCUGAGAACAGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon27 |
miR-6807 directly targets SLC2A8 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6807 | miRNA Mature ID | miR-6807-5p | ||
miRNA Sequence |
GUGAGCCAGUGGAAUGGAGAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon28 |
miR-6829 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6829 | miRNA Mature ID | miR-6829-5p | ||
miRNA Sequence |
UGGGCUGCUGAGAAGGGGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon29 |
miR-6835 directly targets SLC2A8 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6835 | miRNA Mature ID | miR-6835-3p | ||
miRNA Sequence |
AAAAGCACUUUUCUGUCUCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon30 |
miR-762 directly targets SLC2A8 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-762 | miRNA Mature ID | miR-762 | ||
miRNA Sequence |
GGGGCUGGGGCCGGGGCCGAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.